Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Dedicated

Novartis building

Novartis skin cancer drug clears pivotal trial

Sonidegib achieves significant response in basal cell carcinoma patients

- PMLiVE

Actavis acquires Forest for $25bn

Ramps up its shift into speciality pharmaceuticals

- PMLiVE

US and Indian regulators forge closer ties

FDA signs new agreement with India's Ministry of Health and Family Welfare

- PMLiVE

Avillion names Allison Jeynes-Ellis CEO

Her career to date includes experience at ABPI, J&J, Roche, Wyeth, BMS and Novartis

- PMLiVE

Spink wins UEG business

Agency will drive Europe-wide PR for gastroenterology specialists

- PMLiVE

Infographic: Digitally-native HCPs

Key data on the how doctors' use of digital is changing

Are you talking to digital natives?

In 2014, ‘digitally-native HCPs’ will outnumber ‘digital immigrants’ – yet pharma’s marketing spend and strategy still disproportionally targets an ageing and less impressionable demographic

Bayer symbol

Bayer drug cuts infusion burden in haemophilia A

Able to provide longer-term protection against bleeding episodes in late-stage trial

- PMLiVE

Servier signs cancer collaboration with Cellectis

Will target leukaemia and five solid tumours

- PMLiVE

Actavis ‘negotiating $25bn acquisition’ of Forest

Generic company reportedly in late-stage takeover talks

- PMLiVE

Senior changes at EMA

New head of IT and chair of committee for advanced therapies

- PMLiVE

MHRA announces senior appointment

Neil McGuire joins as clinical director of medical devices

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links